The Influence of Tribenoside on Expression and Deposition of Epidermal Laminins in HaCaT Cells
Tribenoside has been used clinically for hemorrhoidal disease associated with coagulation, inflammation, and wounds. However, the pharmacological mechanism of tribenoside activity has never been clear. In this study we examined whether tribenoside affected expression and deposition of laminins that are required for reconstruction of basement membranes (BMs) during wound healing in hemorrhoidal disease. HaCaT cells, which are derived from human epidermis, were treated in growth media supplemented with tribenoside. Reverse transcriptase-polymerase chain reaction (RT-PCR) using primers specific for laminin chains showed that HaCaT cells constitutively expressed laminin a a3, a a5, b b1, b b3, g g1, and g g2 chains. Tribenoside treatment of HaCaT cells did not induce expression of other laminin chains. We also quantified the expression of laminin chains in tribenosidetreated cells using real-time PCR. The expression level of laminin a a3, b b1, b b3, g g1, and g g2 chains was not affected. In contrast, the expression of laminin a a5 in the tribenoside-treated cells was four times higher than that of control cells. Immunocytochemistry also showed that tribenoside accelerated the focal deposition of laminin-332 (a a3, b b3, g g2). These results suggest that tribenoside interacts with epidermal cells and regulates the expression and localization of laminins to help reconstruct BMs in wound healing of hemorrhoids. promoted wound healing in a rat hemorrhoidal disease model. 18) To define the function of tribenoside, we focused on epidermal laminins that are required for reconstruction of BMs in wound healing. In this study we found that the expression and localization of laminins in human epidermal cells were altered by tribenoside.
MATERIALS AND METHODS

Cell Culture
HaCaT cells, an immortalized aneuploid human keratinocyte cell line, 19) were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA, U.S.A.) containing 10% fetal bovine serum (FBS; Invitrogen), 100 units/ml penicillin, and 100 mg/ml streptomycin (Invitrogen). The cells were maintained at 37°C in a humidified 5% CO 2 /95% air atmosphere.
Chemicals Tribenoside, a derivative of glucofuranoside (see Fig. 1A ), was provided by Amato Pharmaceutical Products, Ltd. (Fukuchiyama, Japan). The chemical was kept under deoxygenated conditions until use. Tribenoside was dissolved in dimethyl sulfoxide (DMSO) at 100 mM.
Cell Growth Assay Using 6-well plates, 1.5ϫ10 5 cells were seeded per well in DMEM supplemented with 10% FBS. The next day the cells were exposed to tribenoside for 1 h or 3 h, after which they were placed in tribenoside-free medium. After culture for 2 d, the cells were harvested with Hanks's solution containing 0.25% trypsin-0.02% ethylenediaminetetraacetic acid (EDTA) and counted under the microscope using a hemocytometer.
RNA Purification and Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Total RNA was isolated from the cultured HaCaT cells (QIAGEN, Hilden, Germany). First-strand cDNA synthesis was performed with random hexamer primers using SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA, U.S.A.). The cDNA fragments encoding laminin chains were amplified by RT-PCR using the primer sets listed in Table 1 [20] [21] [22] and under the following conditions: an initial hold at 95°C for 2 min and then 30 cycles at 94°C for 15 s, 53-61°C for 30 s, 68°C for 30-60 s. PCR products were analyzed by electrophoresis using 1.5% agarose gels.
Real-Time PCR The expression of laminin chains was determined by real-time PCR using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, U.S.A.). To quantify the RNA transcripts, cDNA fragments encoding laminin chains were amplified by RT-PCR using the primer sets listed in Table 1 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control to normalize for differences in the amount of total RNA in each sample. Thermocycler conditions included an initial hold at 50°C for 2 min, then 95°C for 10 min; this was followed by a PCR program: 95°C for 15 s, 53-61°C for 30 s, 68°C for 30-60 s for 50 cycles. Data were collected and quantitatively analyzed with ABI PRISM 7000 SDS Software (Applied Biosystems). The mean value of the triplicates for each sample was calculated and expressed as cycle threshold (CT). The amount of gene expression was calculated as the difference (DCT) between the mean CT value of the sample for the laminins and the mean CT value of that sample for the GAPDH. Relative expression was calculated as the difference (DDCT) between the DCT values of the test sample and of the relative control sample. Relative expression of laminins was expressed as 2 -DDCT . Immunocytochemistry Monoclonal antibody 4C7 against human laminin a5 and Hoechst 33258 were purchased from Chemicon (Temecula, CA, U.S.A.) and Sigma (St. Louis, MO, U.S.A.), respectively. Polyclonal antibody against human laminin-332 was kindly provided by Dr. M. Peter Marinkovich (Stanford University, Stanford, CA, U.S.A.). The cells were fixed with 3% paraformaldehyde/ phosphate buffered saline (PBS) (Ϫ) and permeabilized with 1% Triton-X100/PBS (Ϫ). The fixed cells were blocked in 10% normal goat serum and then incubated with primary antibodies. Secondary antibody was conjugated to Alexa488 (Invitrogen, Carlsbad, CA, U.S.A.). After several washes, the cells were mounted in 90% glycerol containing 0.1ϫPBS (Ϫ) and 1 mg/ml p-phenylenediamine. Images captured using Biozero (Keyence, Osaka, Japan) were imported into Adobe Photoshop CS and Adobe Illustrator CS3 (San Jose, CA, U.S.A.) for processing and layout.
RESULTS
Treatment of HaCaT Cells with Tribenoside
Chemicals often exhibit toxicity at high concentrations. To determine the suitable concentration of tribenoside for treatment of HaCaT cells, we tested for toxicity by a cell growth assay. Because tribenoside is insoluble in water, it was dissolved in DMSO at 100 mM. Tribenoside was added to growth media to make final concentrations of 0, 3, 10, 30, and 100 mM. The cells were treated with tribenoside for 1 h or 3 h and then twice washed with growth media to remove the drug. After 2 d in culture, the number of cells in each well was determined. The growth of HaCaT cells was not affected by up to 30 mM tribenoside (Fig. 1B) . In contrast, many cells treated with 100 mM tribenoside detached from the substratum, demonstrating toxicity at the highest concentration. Although we also tried treating the cells with tribenoside for 3 h, cell growth was significantly decreased even at low concentrations. Due to no signs of toxicity, in the remaining studies HaCaT cells were treated with 30 mM of tribenoside for 1 h.
Expression of Laminin Chains in HaCaT Cells Treated with Tribenoside
Our previous study reported that the expression pattern of laminin chains is variable in cultured cells. 22) To examine if the expression pattern of laminin chains was altered in HaCaT cells treated with tribenoside, we performed RT-PCR using the specific primer sets listed in Table 1 . As shown in Fig. 2 , HaCaT cells constitutively expressed laminin a3, a5, b1, b3, g1, and g2, suggesting that these cells secret laminin-511 and -332. After the cells were treated with 30 mM of tribenoside for 1 h, the expression pattern of laminin chains did not differ qualitatively from that of control cells.
Quantitive Analysis of Laminin Chains Expression Although the identity of the laminin chains expressed was not different between control and tribenoside-treated cells, there is a possibility that tribenoside alters laminin expression at a quantitative level. To quantify the expression of laminin chains, we performed real-time PCR using specific primer sets for laminin a3, a5, b1, b3, g1, and g2 chains. The expression of laminin a5 in tribenoside-treated cells was four times higher than that of control cells (Fig. 3A) . In contrast, the expression level of laminin a3, b1, b3, g1, and g2 chains was not affected. We also examined if lower concentration of tribenoside had effects on the expression of laminin a5. As shown in Fig. 3B , LAMA5 gene expression was significantly up-regulated by treatment with 10 mM tribenoside, indicating a dose-dependent regulation by tribenoside.
Localization of Laminins in Tribenoside-Treated Cells
The secreted laminins are trapped by epidermal and/or mesenchymal cells and assembled into BM. 23) Localization of laminins in HaCaT cells treated with tribenoside was examined using immunofluorescence microscopy. The cells were treated with tribenoside for 1 h and then washed twice with growth media to remove tribenoside, as described above. After incubation for 24 h, the tribenoside-treated cells were stained with anti-laminin a5 monoclonal antibody or antilaminin-332 polyclonal antibody. Hoechst 33258 was used to label nuclei. Although the expression of laminin a5 mRNA was up-regulated by tribenoside, the localization of laminins containing a5 was not different between control and tribenoside-treated cells (Fig. 4) . In contrast, although tribenoside did not affect transcription of a3, b3 and g2, there was focal Transcripts for human laminin a1-5, b1-3, and g1-3 chains were amplified by RT-PCR from HaCaT cells using the primer sets listed in Table 1 . The predicted size of the amplified cDNAs were 317 (a1), 170 (a2), 212 (a3), 227 (a4), 197 (a5), 248 (b1), 299 (b2), 1078 (b3), 194 (g1), 603 (g2), and 543 (g3) base pairs. fluorescence for laminin-332 in the treated cells but not in untreated cells.
DISCUSSION
Wound healing is a complex and well-orchestrated biological process requiring the coordinated migration and proliferation of epidermal cells. Wounding is a trigger that causes epidermal cells to generate cytokines, growth factors, and proteases and to synthesize extracellular matrices, all of which can regulate re-epithelialization. Some agents promote wound healing without disturbing the biological process. 24) Tribenoside, used for treatment of hemorrhoidal disease, promotes not only improvement of microcirculation but also wound healing. In human epidermal cells, tribenoside up-regulated the transcription of laminin a5, which is a major component of epidermal BMs. Laminins containing a5 promote cell adhesion and migration of human lung carcinoma cells. 20, 25) Up-regulated laminin a5 may regulate epidermal cell adhesion and migration in the wound region. Although the transcription of laminin a5 was up-regulated, the deposition of laminin a5 was not different between the control and the tribenoside-treated cells. Bair et al. reported that MT1-MMP cleaved laminin a5 chain at multiple sites in human prostate cancer cells. 26) Since MT1-MMP is constitutively expressed in HaCaT cells, 27) the excessive laminin a5 may be degraded to maintain homeostatic level.
Tribenoside had no effect on the expression of laminin-332 (a3, b3, and g2) in HaCaT cells. A previous study reported that wounding activates transcription of laminin a3 in epidermal cells.
28) The transcription of laminin a3, b3, and g2 chains in proliferative HaCaT cells may have already reached plateau. Deposition of laminin-332 over exposed dermal tissues in epidermal wounds is required for the repair of the BM and for re-establishing hemidesmosomes. 8) In the tribenoside-treated HaCaT cells, focal deposition of laminin-332 was observed. Tribenoside may accelerate the deposition of laminin-332 in epidermal wound healing.
Tribenoside differentially regulated expression and deposition of laminins in HaCaT cells. Laminin a5 is a major molecule to form epidermal BM. The up-regulated expression of laminin a5 seems to be necessary to provide a5-containing laminins on re-construction of BM in epidermal wounds. On the other hand, laminin-332 plays a pivotal role in anchorage of the epithelium to the BM in hemidesmosomes. The focal deposition of laminin-332 seems to lead to the formation of hemidesmosome. Although the expression of laminin-332 was not promoted by tribenoside, it should be enough to establish hemidesmosomes. Differential expression and deposition of laminins in epidermal cells treated with tribenoside may help reconstruct BMs in wound healing of hemorrhoids.
In this study HaCaT cells were treated with 30 mM tribenoside for 1 h. Clinically, 11.3% tribenoside in ointment is used for hemmorrhoidal disease. It is difficult to compare the concentration of tribenoside between in vitro and in vivo. However, since treatment of tribenoside is temporary in vivo, the treatment for 1 h seems to be propriety in vitro use.
In conclusion, our in vitro study suggest that tribenoside interacts with epidermal cells and regulates the expression and localization of laminins to reconstruct the BMs in wound healing of hemorrhoids. Hemorrhoids in vivo are complex disease involving coagulation, inflammation, and wounds. Although it is still unclear how tribenoside cures hemorrhoidal disease, our results provide one clue to help clarify the pharmacological mechanism in wound healing in vitro and in vivo.
